[Radical Operation and Recurrence Prevention with Azulfidine in Crohn Disease: a Prospective Multicenter Study--initial Results]
Overview
Authors
Affiliations
The influence of radical versus more restricted operation and Azulfidine prophylaxis was studied in a controlled, partially randomized double blind multicenter trial (16 centres) in 177 patients over 3 years. Early relapse occurred more frequently in the radically operated group (49 vs. 31%) and less frequently under Azulfidine prophylaxis (34 vs. 46%). The radical operation had no advantage over the more restricted procedure and should be abandoned in Crohn's disease.
Creeping fat formation and interaction with intestinal disease in Crohn's disease.
Yin Y, Xie Y, Ge W, Li Y United European Gastroenterol J. 2022; 10(10):1077-1084.
PMID: 36507842 PMC: 9752293. DOI: 10.1002/ueg2.12349.
Iheozor-Ejiofor Z, Gordon M, Clegg A, Freeman S, Gjuladin-Hellon T, MacDonald J Cochrane Database Syst Rev. 2019; 9:CD013210.
PMID: 31513295 PMC: 6741529. DOI: 10.1002/14651858.CD013210.pub2.
Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.
Gjuladin-Hellon T, Gordon M, Iheozor-Ejiofor Z, Akobeng A Cochrane Database Syst Rev. 2019; 6:CD008414.
PMID: 31220875 PMC: 6586553. DOI: 10.1002/14651858.CD008414.pub3.
Aminosalicylates for induction of remission or response in Crohn's disease.
Lim W, Wang Y, MacDonald J, Hanauer S Cochrane Database Syst Rev. 2016; 7:CD008870.
PMID: 27372735 PMC: 6457996. DOI: 10.1002/14651858.CD008870.pub2.